Stockreport

Alder Biopharmaceuticals: Pure Play Migraine Prevention Treatment In A Crowded Space [Seeking Alpha]

ALDER BIOPHARMACEUTICALS INC  (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806
PDF Summary The Migraine prevention market is estimated to be around $8 billion . Based on the number of migraineurs and the cost per treatment, that might be low. [Read more]